| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/06/2004 | WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 05/06/2004 | WO2004037171A2 Mitotic kinesin inhibitors |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/06/2004 | WO2004022041A3 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 05/06/2004 | WO2004018463A3 Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| 05/06/2004 | WO2004018457A8 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004018449A8 Piperidine-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004013131A3 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/06/2004 | WO2004005281A8 Inhibitors of tyrosine kinases |
| 05/06/2004 | WO2004004715A3 Novel delta opioid receptor ligands |
| 05/06/2004 | WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003051837A8 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2003037889A8 Compounds and method for the treatment of overactive bladder |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087789 Treating Alzheimer's disease, peripheral neuropathy, seizure disorder and/or diabetes |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087638 Antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders; side effect reduction |
| 05/06/2004 | US20040087628 Enzyme inhibitors; antiarthritic agents; psoriasis; viricides; bactericides |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087621 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 05/06/2004 | US20040087619 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 05/06/2004 | US20040087601 Pyrimidine derivatives as IL-8 receptor antagonists |
| 05/06/2004 | US20040087592 Treatment of malaria with farnesyl protein transferase inhibitors |
| 05/06/2004 | US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087584 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087573 Phenylpiperidines and phenylpyrrolidines |
| 05/06/2004 | US20040087570 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040086907 Prevent Dna damage; antitumor, anticancer agents; blocking epidermal growth factor receptor |
| 05/06/2004 | US20040086745 Emits bluish light with a high purity of color |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1414817A1 Substituted isoindoles and e use thereof |
| 05/06/2004 | EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414808A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414462A2 Treatment of renal fibrosis |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414452A1 Novel substituted benzimidazole dosage forms and method of using same |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261602B1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP1000033B1 Heterocyclic derivatives which inhibit factor xa |
| 05/06/2004 | CA2504272A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 05/06/2004 | CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | CA2503462A1 Selected cgrp antagonists, processes for preparing them and their use aspharmaceutical compositions |
| 05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/06/2004 | CA2503024A1 Process for making pyrazole compounds |
| 05/06/2004 | CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | CA2502819A1 Inhibitors of glycogen synthase kinase 3 |
| 05/06/2004 | CA2501231A1 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | CA2500848A1 Mitotic kinesin inhibitors |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494530A Heterocyclic diamide invertebrate pest control agents |
| 05/05/2004 | CN1493562A Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/05/2004 | CN1148358C 1-substituted-4-carbamoyl-1,2,4-triazol-5-one derivatives and herbicide |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148356C Benzosulfone derivatives |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148189C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
| 05/05/2004 | CN1148183C Indoly-3-glyoxylic acid derivatives with antitumoral activity |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730684 Key regulatory point in the overall synthetic pathway of bacterial fatty acid biosynthesis; fabi is an ideal target for antibacterial intervention |